What is included in the treatment for Guillain-Barré syndrome?

What is included in the treatment for Guillain-Barré syndrome?

• A. Antibiotics
• B. Steroids
• C. Physical therapy
• D. Supportive care, plasmapheresis

Answer: (D)

Guillain-Barré syndrome is an acute autoimmune neuropathy where the priority is twofold: support the patient through potential respiratory failure and autonomic instability, and actively modulate the immune attack on the nerves. Plasmapheresis (plasma exchange) is one of the main disease-modifying treatments because it rapidly removes circulating autoantibodies and inflammatory mediators that drive demyelination and nerve damage. When started early, typically within two weeks of onset, it can shorten the time to recovery and improve outcomes. Pairing this with thorough supportive care—continuous monitoring, airway and ventilatory support if needed, nutrition, prevention of complications like DVT and infection, pain management, and early mobilization—addresses the life-threatening risks and supports rehabilitation. Antibiotics are not used to treat the neuropathy itself, since the condition is autoimmune rather than infectious. Steroids alone have not shown benefits in altering the course of GBS. Physical therapy is indeed important for recovery, but the combination of supportive care with plasmapheresis reflects the standard approach to acute management.

Guillain-Barré syndrome is an acute autoimmune neuropathy where the priority is twofold: support the patient through potential respiratory failure and autonomic instability, and actively modulate the immune attack on the nerves. Plasmapheresis (plasma exchange) is one of the main disease-modifying treatments because it rapidly removes circulating autoantibodies and inflammatory mediators that drive demyelination and nerve damage. When started early, typically within two weeks of onset, it can shorten the time to recovery and improve outcomes. Pairing this with thorough supportive care—continuous monitoring, airway and ventilatory support if needed, nutrition, prevention of complications like DVT and infection, pain management, and early mobilization—addresses the life-threatening risks and supports rehabilitation.

Antibiotics are not used to treat the neuropathy itself, since the condition is autoimmune rather than infectious. Steroids alone have not shown benefits in altering the course of GBS. Physical therapy is indeed important for recovery, but the combination of supportive care with plasmapheresis reflects the standard approach to acute management.